SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001601485-21-000017
Filing Date
2021-05-17
Accepted
2021-05-17 06:03:24
Documents
84
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q angn-20210331.htm   iXBRL 10-Q 1769541
2 EX-31.1 ex311_angnx03312021-10q.htm EX-31.1 10573
3 EX-31.2 ex312_angnx03312021-10q.htm EX-31.2 10019
4 EX-32.1 ex321angn-03312021x10q.htm EX-32.1 6487
5 EX-32.2 ex322_angnx03312021-10q.htm EX-32.2 6040
  Complete submission text file 0001601485-21-000017.txt   8439707

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT angn-20210331.xsd EX-101.SCH 65249
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT angn-20210331_cal.xml EX-101.CAL 78621
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT angn-20210331_def.xml EX-101.DEF 362674
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT angn-20210331_lab.xml EX-101.LAB 764134
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT angn-20210331_pre.xml EX-101.PRE 532531
11 EXTRACTED XBRL INSTANCE DOCUMENT angn-20210331_htm.xml XML 1212021
Mailing Address 51 CHARLES LINDBERGH BOULEVARD UNIONDALE NY 11553
Business Address 51 CHARLES LINDBERGH BOULEVARD UNIONDALE NY 11553 (415) 655-4899
Angion Biomedica Corp. (Filer) CIK: 0001601485 (see all company filings)

IRS No.: 113430072 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39990 | Film No.: 21927266
SIC: 2834 Pharmaceutical Preparations